Rifaximin co-treatment showed a trend towards a reduction of apoptotic cells, suggesting a protective effect against chemotherapy-induced epithelial cell death ( Figure 1J–K ).
← all excerpts
Muribaculum as a microbial contributor of rifaximin-induced mucosal protection during chemotherapy.
1
—
—